Shionogi

4507.TSE

17.81 USD

-0.17

-0.95%

Overview

Last close

17.81 usd

Market cap

15.16B usd

52 week high

18.38 usd

52 week low

12.04 usd

Target price

17.26 usd

Valuation

P/E

13.1051

Forward P/E

15.4083

Price/Sales

5.0677

Price/Book Value

1.6413

Enterprise Value

11.71B usd

EV/Revenue

3.9244

EV/EBITDA

7.455

Key financials

Revenue TTM

3.00B usd

Gross Profit TTM

2.58B usd

EBITDA TTM

1.26B usd

Earnings per Share

1.36 usd

Dividend

0.42 usd

Total assets

10.30B usd

Net debt

-2.37B usd

About

Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.